Bills/H.R. 2553

Capping Prescription Costs Act of 2025

Capping Prescription Costs Act of 2025

In CommitteeHealthcareHouseHouse Bill · 119th Congress
Bill Progress · House
Introduced
Committee
Passed House
Passed Senate
Passed Both
Signed

Plain Language Summary

# Capping Prescription Costs Act of 2025 - Summary **What the Bill Would Do** This bill aims to lower prescription drug costs for American consumers by capping how much patients have to pay out-of-pocket for medications. The legislation would place limits on copayments and coinsurance (the percentage of drug costs patients must cover), making prescription drugs more affordable for people with insurance coverage. By reducing the financial burden of medications, the bill intends to help patients better afford necessary treatments and manage chronic health conditions. **Who It Affects** The bill primarily affects people with health insurance who currently struggle with high prescription drug costs.

It would also impact pharmaceutical companies, insurance companies, and healthcare providers, though regulations would apply specifically to patient cost-sharing rather than drug prices themselves. **Current Status** As of now, HR 2553 is in committee, meaning it's still in the early stages of the legislative process and has not yet been debated or voted on by the full House of Representatives. The bill was introduced by Representative Steven Horsford (D-Nevada) in the 119th Congress.

Advertisement

Latest Action

April 1, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Subjects

Health care costs and insurancePrescription drugs

Sponsor

8 cosponsors

Key Dates

Introduced
April 1, 2025
Last Updated
April 1, 2025
Read Full Text on Congress.gov →
Advertisement